CNS PHARMACEUTICALS INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 18978H508 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Stonepine Capital Management, LLC 13G/A	9.9%	159,790	13G/A	5/15/2026 Event 3/31/2026
Stonepine Capital Management, LLC	9.9%	159,790
Stonepine Capital, L.P.	9.9%	159,790
Stonepine GP, LLC	9.9%	159,790
Jon M. Plexico	9.9%	159,790
Ikarian Capital, LLC 13G/A	9.9%	147,290	13G/A	8/14/2026 Event 6/30/2026
Ikarian Capital, LLC	9.9%	147,290
Neil Shahrestani	9.9%	147,290

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	11	280 k	$1.34 M	$0
2026 Q1	11	146 k	$349 k	$0
2025 Q4	9	124 k	$652 k	$0
2025 Q3	8	24.6 k	$222 k	$0
2025 Q2	1	13.0	$11.00	$0